Nicolas Bertrand
Chercheur universitaire
Axe Endocrinologie et néphrologie
Publications
View all-
article Coutu K, Dupré C, Gaudreault N, Ngabonziza Sangwa A, Bertrand N, Greschner AA, Gauthier MA
Quantitative recovery of methoxy poly(ethylene glycol) and PEGylated nanosystems from complex biological matrices
Nanoscale Adv 8 (16), 2026.
-
article Liao S, Fox K, Birkenshaw A, Wadhwa A, Wang S, Bedard K, Gaudreault N, Rekve J, Cheng MHY, Bertrand N, Foster LJ, Harder KW, Ross CJD, Badea I, Blakney AK, Cullis PR
Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection
J Control Release 396 2026.
-
article Roussel S, Carrera Fragoso L, Grenier P, Bruxelles Q, Chénard V, Marcoux S, Greffard K, Fortin S, Vallières L, Bertrand N
Correction to “Glycerol-Based Polymer to Improve the Cellular Uptake of Liposomes”
Biomacromolecules 27 (1), 2026.
Projects
- Methods to study the long-term effects of nanoparticles in vivo, from 2023-04-01 to 2028-03-31
- Causes and consequences of anti-PEG antibodies, from 2023-10-01 to 2028-09-30
- Plateforme d'évaluation de la biopharmacie des nanomédicaments, from 2024-04-01 to 2027-03-31
- NSERC CREATE in nanoparticles characterization: Innovation in Cascade Assays and Reaction to biological Environments for future nano medicines (ICARE-Nanomed), from 2026-04-01 to 2032-03-31
- Nanopharmacologie et nanomédecine: aider le Québec à atteindre la maturité dans le domaine des nanomédicaments, from 2026-07-01 to 2030-03-31
- Pharmacological optimization of OpKemo, a silica-based nanoparticle platform for oncology, from 2022-01-31 to 2024-12-31
- Nanopharmacologie et nanosciences pharmaceutiques : une approche multidisciplinaire pour des nanomédecines plus efficaces et mieux tolérées, from 2022-07-01 to 2026-06-30
- Anti-PEG antibodies and adverse reactions to PEGylated drugs: effect of mRNA vaccination and novel mitigation strategies., from 2022-09-01 to 2025-08-31
- Development, optimization and evaluation of novel nanoparticle formulations for extra-hepatic targeted gene therapy, from 2022-12-05 to 2024-12-04
- Nanomatériaux pour cibler le microbiote intestinal et altérer le métabolisme des acides biliaires, from 2023-04-01 to 2026-03-31
- NanoQB : réseau Québec-Brésil pour la recherche collaborative en nanotechnologie pharmaceutique, from 2023-07-21 to 2025-11-30
- Have mRNA vaccines changed the biopharmacy of drugs? A pilot correlative study on the links between vaccination with mRNA vaccines and the incidence of acute infusion reactions in women with breast and ovarian cancer treated with, from 2023-04-01 to 2025-03-31